CD99 exhibits an oncogenic function, which showed strong expression levels on various cancer cell types, including T cell lineage leukemia/lymphoma, Ewing sarcoma (EWS), breast cancer, acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS) [25–27]. This evidence concerns the gene CD99 and acute myeloid leukemia.